Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation

2019 ◽  
Vol 99 (2) ◽  
pp. 389-390
Author(s):  
Kyosuke Yamaguchi ◽  
Yasushi Kubota ◽  
Chiyuki Kishimori ◽  
Hitoshi Ohno ◽  
Keisuke Kidoguchi ◽  
...  
2019 ◽  
Vol 30 (3) ◽  
pp. e259-e262 ◽  
Author(s):  
Sara Ferreira dos Santos Costa ◽  
André Myller Barbosa Silva ◽  
Gleyson Kleber Amaral-Silva ◽  
Hélder Antônio Rebelo Pontes ◽  
Flávia Sirotheau Corrêa Pontes ◽  
...  

Haigan ◽  
2019 ◽  
Vol 59 (2) ◽  
pp. 142-146
Author(s):  
Hirofumi Takenaka ◽  
Naruaki Kawasaki ◽  
Futoshi Ishiguro ◽  
Atsushi Enomoto ◽  
Takashi Abe ◽  
...  

2021 ◽  
Author(s):  
Mobin Paul ◽  
Latha Abraham ◽  
MP Sophy ◽  
Dasary Varghese ◽  
Chryselle Olive D'Souza

Epstein Barr virus - positive (EBV+) diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS), is a newly recognized rare aggressive B- cell neoplasm with a wide morphologic spectrum. Metachronously developed B- cell and T- cell composite lymphoma (CL) is quite rare. We report a case of an elderly male who presented with enlarged abdominal lymph nodes and diagnosed as EBV+ DLBCL, NOS. He was started on chemotherapy which had to be discontinued after three cycles due to life threatening Pneumocystis carinii pneumonia and poor performance status. While on follow up, within two years, the patient presented with features of relapse. A repeat histopathological examination of the lymph node showed features of Peripheral T cell lymphoma, not otherwise specified (PTCL, NOS) and the clonality was confirmed by T- cell receptor gamma chain rearrangement assay. More studies are needed to understand the association of EBV+ DLBCL, NOS with other lymphomas.


2010 ◽  
Vol 34 (3) ◽  
pp. 377-384 ◽  
Author(s):  
Dylan V. Miller ◽  
Dennis J. Firchau ◽  
Rebecca F. McClure ◽  
Paul J. Kurtin ◽  
Andrew L. Feldman

Sign in / Sign up

Export Citation Format

Share Document